AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $31.26 Per Share, $10.1 Billion Nov 30, 2023 07:31AM
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio Nov 30, 2023 07:30AM
ImmunoGen Reports Recent Progress and Third Quarter 2020 Financial Results Nov 6, 2020 06:30AM
Trading Radar for 04/26: Chevron (CVX), Burger Kinds (BKW), Weyerhaeuser (WY), Goodyear (GT), Olin (OLN), Apr 25, 2013 05:57PM
Notable Analyst Rating Changes 08/22: (CSIQ) (CNP) (CX) Upgraded; (CLWR) (TSL) (FGP) Downgraded Aug 22, 2012 10:48AM


Apr 26, 2012 06:06PM Trading Radar for 04/27: Ford (F), Procter & Gamble (PG), Covidien (COV), Goodyear (GT), Merck & Co. (MRK) Report
Oct 26, 2011 05:30PM Trading Radar for 10/27: Exxon (XOM), Dow Chemical (DOW), Baidu.com (BIDU), Procter & Gamble (PG), AMD (AMD) Report
Jul 13, 2009 10:05AM Lazard Capital Downgrades ImmunoGen (IMGN) to Hold